News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Clinical News & Stories
Clinical, In the Media, Research
Rising WashU Medicine Physician-Scientist Researches Ways to Prevent Recurrence in AML
Francesca Ferraro receives Damon Runyon Clinical Investigator Award for her acute myeloid leukemia work Francesca Ferraro, MD, PhD, a WashU Medicine researcher and medical oncologist at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, has been named a 2026 Damon Runyon Clinical Investigator Award. The grant, given by the Damon Runyon Cancer Research Foundation, supports early-career […]
Clinical, In the Media, Research
WashU Medicine Researchers at Siteman Earn National Recognition for Leukemia Research
American Society of Hematology awards grants to Francesca Ferraro, Jaebok Choi Two WashU Medicine investigators at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, have been awarded prestigious grants from the American Society of Hematology (ASH), the world’s largest professional society serving clinicians and scientists working to conquer blood diseases. Francesca Ferraro, MD, […]
Clinical, In the Media, Research
Jessica Silva-Fisher Receives American Cancer Society Grant
WashU Medicine investigator at Siteman Cancer Center aims to study how chemical modifications to RNA contribute to the progression of multiple myeloma Jessica Silva-Fisher, PhD, a WashU Medicine scientist at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, has received a Research Scholar Grant from the American Cancer Society (ACS) — one of only […]
Clinical, In the Media, Research
Newly Approved Pancreatic Cancer Treatment Has Been Shown To Prolong Life — And Highlights Siteman’s Role in Bringing Innovation to Patients
FDA approves first-in-class drug trialed at WashU Medicine and Siteman Cancer Center — a new option for patients with metastatic disease Daraxonrasib is a drug that targets RAS proteins, which are mutated in more than 90% of pancreatic cancers. As a clinical trial site, Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine evaluated the […]
Clinical, Research
mRNA-Based Therapy Offers New Hope Against High-Risk Melanoma
Siteman Cancer Center served as a major, early clinical trial site for groundbreaking vaccine In a major announcement, an experimental mRNA vaccine has been shown in global clinical trials to prevent melanoma from returning or spreading in high-risk melanoma patients when combined with the immunotherapy drug pembrolizumab, known commercially as Keytruda, and given after surgery. The […]
Clinical, In the Media, Staff/Faculty Update
WashU Medicine Appoints New Chief of Head and Neck Surgery
Andrés M. Bur, MD, FACS, a nationally known oncologist and reconstructive surgeon, will also co-lead the Head and Neck Tumor Center at Siteman Cancer Center Andrés M. Bur, MD, FACS, has been named chief of the Division of Head and Neck Surgery in the Department of Otolaryngology — Head & Neck Surgery at WashU Medicine […]
Clinical, In the Media, Research
New Approach to Designing Drugs Supercharges Cancer Medication
Shape-shifting drug hits tumors in multiple ways, improves outcomes in mice Modern anticancer medications that combine tumor-fighting drugs with proteins that specifically target cancer cells are a relatively new class of drug, often given to patients for whom standard chemotherapy has not worked. The drugs are precise, but can attack only one kind of target […]
Clinical, In the Media, Research
The Future of Brain Tumor Care is Being Built Now — at Siteman Cancer Center
WashU Medicine experts at Siteman’s Brain Tumor Center are accelerating the science that will create a new standard and new survivorship for brain tumor care For years, progress against glioblastoma has been measured in small steps with only slight improvements in survival. Now, at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, bold research and remarkable advances against this deadliest form of […]
Clinical, In the Media
Siteman Cancer Center Radiation Therapy Recognized for Excellence
Reaccreditation by the American Society for Radiation Oncology underscores Siteman’s enterprise-wide commitment to adult and pediatric patient-centered care The Department of Radiation Oncology at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has again been recognized as one of the best radiation oncology centers in the nation. The recognition comes from its reaccreditation by the American Society […]
Clinical, In the Media, Research
Tumor Markers May Help Doctors Decide Which Head and Neck Cancer Patients Need Immunotherapy Before Surgery
WashU Medicine physician-scientists at Siteman Cancer Center identify a promising way to help guide immunotherapy treatment decisions and enhance patient care Building upon more than a decade of investigator-initiated clinical trials at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, researchers have identified a malignant cell biomarker that may predict which patients will respond to the […]